C2I2.org
 Index to all volumes
  2008
  2007
  2006
  2005
  2004
  2003
 Useful web site addresses
 Contacting C2I2

Search for:
Type a word or a phrase. All forms of the word are searchable.

Click here to register to get free access to the newest editions on-line

Supported by


Dr Oliver Strohm trained at Heidelberg, San Antonio and Berlin and currently holds an appointment as Associate Professor at the University of Calgary. His clinical and scientific interest is the application of cardiovascular MRI in large-volume centres. His focus is on dilated forms of cardiomyopathies and the characterization of inflammatory and fibrotic changes in the myocardium in ischaemic and non-ischaemic cardiomyopathies.

Dr Strohm is Deputy Director of the Stephenson CMR Centre at the Libin Institute of Alberta and Head of the Cardiovascular MRI training programme.

He is a Fellow of the European Society of Cardiology and works as a cardiologist for the Calgary Health Region.
Stress Cardiovascular MR Imaging

Oliver Strohm and Matthias G. Friedrich
Dept. of Cardiac Sciences and Radiology, University of Calgary, Calgary, Alberta, Canada

Address for correspondence:
Oliver Strohm, MD, FESC
Stephenson CMR Centre, Departments of Cardiac
Sciences and Radiology, University of Calgary, Suite
700 – SSB, Foothills Medical Centre, 1403 29th St. NW,
Calgary, Alberta, T2N 2T9, Canada
Tel: +1-(403)-944-8806 Fax: +1-(403)-944-8510
Email: oliver.strohm@ucalgary.ca

Abstract
Stress testing in patients with ischaemic heart disease is commonly applied in clinical practice. Cardiovascular MRI has the ability to obtain precise information about left ventricular function, inducible myocardial ischaemia during pharmacological stress and viability in an integrated examination. Adenosine may be used for vasodilatory stress for first-pass perfusion studies and dobutamine stress may be used to monitor wall motion abnormalities. After i.v. application of gadolinium-based contrast agents, areas of fibrosis or chronic infarcts are detected and may be characterized as ‘ischaemic’ or ‘non-ischaemic’ scar. The high image quality and the well-tolerated contrast agents may allow cardiovascular MRI to evolve into a routine tool for the serial assessment of patients with known or suspected ischaemic heart disease.